JP Morgan Maintains Neutral on Progyny, Raises Price Target to $30

Benzinga · 1d ago
JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $27 to $30.